MedTrace Logo

The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

NCT02477852 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-06-23

No results posted yet for this study

Summary

The purpose of this study is to determine the better preoperative anti-tuberculosis treatment period of patients with spinal tuberculosis.

Conditions

  • Tuberculosis, Spinal

Interventions

DRUG

Isoniazid

preoperative treatment of spinal tuberculosis with Isoniazid

DRUG

Rifampicin

preoperative treatment of spinal tuberculosis with Rifampicin

DRUG

Ethambutol

preoperative treatment of spinal tuberculosis with Ethambutol

DRUG

Pyrazinamide

preoperative treatment of spinal tuberculosis with Pyrazinamide

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER

  • Beijing Chest Hospital

    lead OTHER

Principal Investigators

  • shao fa xu, doctor · Beijing Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477852 on ClinicalTrials.gov